Takuna 2 fl oz Nutramedix

Takuna is an extract produced from the bark of Cecropia strigosa, a tree that is found throughout South America. It has recently been found to have very powerful antiviral properties as well as some other general antimicrobial properties. Practitioners using the product have found that Takuna given every hour usually resolves influenzas in just a few hours. In some cases, the symptoms are resolved in as little as one hour. Practitioners also report that Takuna is effective against some bacterial infections and some fungal infections.

$64.95

Takuna 2 fl oz Nutramedix

Description

TAKUNA
MICROBIAL DEFENSE
FOR FIGHTING:

COLDS
FLU
VIRAL HEPATITIS
SHINGLES
CYTOMEGALOVIRUS
EPSTEIN-BARR VIRUS
ACUTE AND CHRONIC VIRAL ENCEPHALITIS AND MENINGITIS

General Description
Takuna is an extract produced from the bark of Cecropia strigosa, a tree that is found throughout South America. It has recently been found to have very powerful antiviral properties as well as some other general antimicrobial properties. Practitioners using the product have found that Takuna given every hour usually resolves influenzas in just a few hours. In some cases, the symptoms are resolved in as little as one hour. Practitioners also report that Takuna is effective against some bacterial infections and some fungal infections.

Some Reported Medicinal Properties
ANTI-AMENORRHEAL

ANTI-ASTHMATIC

ANTIBACTERIAL

ANTI-DIABETIC

ANTI-FEVER

ANTI-FREE RADICALS

ANTIFUNGAL

ANTI-HYPERPLASIA

ANTI-INFLAMMATORY

ANTI-MUCOSAL

ANTIOXIDANT

ANTI-PAIN

ANTI-PARKINSONISM

ANTI-SPASMODIC

ANTIVIRAL

DECONGESTANT

HYPOTENSIVE

PURGATIVE

Research On NutraMedix Product
IN VITRO – LYME DISEASE

Priyanka A.S. Theophilus M.S., Eva Sapi Ph.D. (2013). In Vitro Effect of Peruvian Antimicrobial Agents on Borrelia burgdorferi Full Article

IN VIVO – ANTI-INFLAMMATORY

At the University of Guayaquil, Ecuador, Takuna produced an anti-inflammatory effect 73% as strong as Feldeneas an anti-inflammatory. Full Article

IN VIVO – ACUTE ORAL TOXICITY TESTS

An Acute Oral toxicity study was conducted by the Department of Chemical Sciences at the University of Guayaquil, Ecuador. The general conclusion was that Takuna did not produce toxic effects when used in accordance to the guidelines described in OECD TG 423, thus the product is considered practically innocuous for humans when administered in the acute form. Therefore; studies of acute toxicity at higher doses in humans are not necessary. Full Article

https://www.nutramedix.ec/products/takuna